1 School of Life Sciences, Queensland University of Technology, GPO Box 2434, Brisbane, Australia
2 University of Queensland, Department of Surgery, Royal Brisbane Hospital, Brisbane, Australia
3 Princess Alexandra Hospital, Brisbane, Australia
Correspondence
Peter Timms
p.timms{at}qut.edu.au
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The GenBank/EMBL/DDBJ accession numbers for the sequences reported in this paper are: CpnB, AY426606; CpnC, AY426607; CpnIII, AY427827.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
While C. pneumoniae has been thought of primarily as a human-specific pathogen, several studies have now shown that C. pneumoniae-like stains are also present in a range of animals, including horses (Storey et al., 1993), koalas (Bodetti & Timms, 2000
; Wardrop et al., 1999
), reptiles and amphibians (Berger et al., 1999
; Bodetti et al., 2002
; Reed et al., 2000
). Of the animal infections reported, a total of four non-human genotypes of C. pneumoniae have been described (Bodetti et al., 2002
; Girjes et al., 1994
; Glassick et al., 1996
; Storey et al., 1993
; Wardrop et al., 1999
). These non-human isolates all appear to have relatively minor, but potentially important, sequence differences when compared to the published human genotypes (99·299·4 % homology). These sequence differences range from 1 bp variation over 342 bp for the groESL gene (human versus koala) to 21 bp variations over 279 bp for the ompAVD4 gene (human versus horse) (Wardrop et al., 1999
). A single report has found that various reptiles and amphibians are infected with the same or very similar genotype of C. pneumoniae as humans, as the samples were 100 % identical at the 16S rRNA gene and ompA loci (Bodetti et al., 2002
). In the present study, we used PCR and genotyping of the C. pneumoniae positives from patients with CAD to test the hypothesis that infected individuals have a single genotype of C. pneumoniae present in their plaque and that this genotype is common among other CAD patients.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Human CAD samples.
This study analysed a subset of 10 patients from a larger cohort of 54 CAD patients who were undergoing elective surgery (carotid endartectomy). Atherosclerotic plaques removed at the time of surgery were immediately fixed in 10 % formaldehyde and later decalcified and paraffin-embedded. DNA was extracted from 30 µm-thick sections of paraffin-embedded carotid tissue from each patient using the QIAamp Tissue Kit (Qiagen). The 60 µl of resultant DNA extract was stored at 70 °C until tested. In six patients, multiple sections from the same carotid plaque were tested to confirm the presence of the bacteria throughout the atherosclerotic carotid artery.
Human PBMC specimens.
From 43 individuals from the same cohort of CAD patients, the PBMC fraction was separated from 8 ml of venous blood using Vacutainer CPT cell preparation tubes (Becton Dickinson). The mononuclear cells were isolated, washed twice with PBS and resuspended in 0·5 ml PBS. The samples were heat-treated at 100 °C for 10 min and stored at 70 °C until tested.
Non-human C. pneumoniae genotypes.
Given that our results showed that some of the human samples we analysed harboured a genotype of C. pneumoniae that is similar/identical to those previously found in koalas, we subsequently genotyped additional strains of C. pneumoniae from a previous koala study in our laboratory to examine whether only non-human strains of C. pneumoniae are present in koalas (Bodetti & Timms, 2000).
ompA PCR.
The VD4 region of the ompA gene was selected as a target for genotyping, as the maximum variability between non-human and human isolates of C. pneumoniae has been reported in this small region (Wardrop et al., 1999). C. pneumoniae DNA within human carotid specimens and within PBMCs from humans and koalas was detected using a nested PCR assay targeting a 366 bp fragment of the C. pneumoniae ompA gene (Bodetti & Timms, 2000
). The nested PCR used was highly specific, and could detect down to 10 chlamydial bodies. For both rounds, DNA (minimum concentration 10 ng per PCR) was amplified in 25 µl volumes containing 1 µM of primers, 200 µM deoxyribonucleotides, 1x PCR buffer, 1·2 U Taq polymerase and 1 µl DNA sample or first-round template. Each sample was tested in duplicate and run in conjunction with controls: positive controls containing 100 copies of C. pneumoniae 446 bp first-round PCR product, and negative controls with no template added.
ygeDurk PCR.
The C. pneumoniae strains CWL029 and AR39 differ in the plasticity zone between the ygeD and urk genes by the orientation of a 23 bp sequence (Read et al., 2000). Therefore, a 568 bp fragment spanning this target region was amplified using a nested PCR. Only the human C. pneumoniae reference strains and the clinical samples that were 100 % identical at the ompA locus to the koala type 1 strain were analysed. A 1 µl volume of each sample was added to a 25 µl reaction mix containing 1 µM of each primer (5'GTTAGGGTGGTTTTCCCAGC3' and 5'GAGATAACGATTCTGAGGCC3'), 1x Boehringer Mannheim PCR buffer, 200 µM each deoxyribonucleotide (Boehringer Mannheim) and 1·2 U Taq polymerase (Boehringer Mannheim). Cycling conditions consisted of an initial denaturation for 5 min at 95 °C, followed by 40 cycles of denaturation at 94 °C for 1 min, annealing at 56 °C for 1 min and extension for 1 min at 72 °C, and a final extension for 10 min at 72 °C. For second-round PCR, 1 µl of the first-round product was mixed with 25 µl of the above amplification mixture, using the nested primers 5'CCAGAACCTCCTGTAATTCC3' and 5'GCTGTTCTACAAGCAAATCACC3'. The PCR parameters were kept constant, except for the annealing temperature of 50 °C. Each sample was tested in conjunction with controls: negative controls with no template added, and positive controls containing 100 copies of C. pneumoniae first-round PCR product. Negative controls were included after every third test sample to check for aerosol contamination. The PCR products were visualized by ethidium bromide staining following electrophoretic separation.
Genotyping.
ompA and ygeDurk PCR products were separated by gel electrophoresis and excised from the gel using a commercial Gel Extraction Kit (Qiagen). Sense and anti-sense strands were sequenced using BigDye Terminator Chemistry in an ABI 3730xl automatic capillary DNA sequencer (Australian Genome Research Faculty, Brisbane, Australia). All samples were confirmed as C. pneumoniae using a BLAST search at http://www.ncbi.nlm.nih.gov/blast. eclustalw in WebANGIS was used to align the sequences of the test samples and to compare the results to various reference C. pneumoniae isolates, including AR39, CM1, CV3, CWL029, IOL207, J138, TW10, TW183, VR1356 and WA97001. AR39, WA97001 and Koala type 1 sequences were obtained from the GenBank database, while all other isolates were genotyped in our laboratory from culture-propagated material.
Cloning.
Any carotid plaque specimen that harboured more than one genotype of C. pneumoniae was cloned to determine the ratio of each genotype present. The pGEM-T Easy Vector System was employed for ligation and transformation of the PCR products into JM109 competent cells, as per the manufacturer's protocol (Promega). For each PCR reaction, 10 individual clones were genotyped.
![]() |
RESULTS AND DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
The detection of C. pneumoniae in human carotid atheromas supports a role for this organism in atherogenesis. Previous studies have shown that the C. pneumoniae strains infecting humans appear to be almost clonal, as the available sequence data show nearly identical sequences for ompA, ompB, the 16S rRNA gene, domain I of the 23S rRNA gene, the16S23S rDNA intergenic spacer, Rnase P RNA, groESL, pmp121, the genes for the 53 and 76 kDa proteins, dnaK and waaA (kdtA) (Everett & Andersen, 1997; Gaydos et al., 1992a
,b
; Herrmann et al., 1996
; Jackson et al., 1997
; Jantos et al., 1997
; Kuo et al., 1993
; Maass et al., 1998a
; Molestina et al., 1998
; Pettersson et al., 1997
; Read et al., 2000
; Shirai et al., 2000a
,b
). Only three studies have genotyped samples obtained from plaque material (Kuo et al., 1993
; Maass et al., 1998a
; Ramirez, 1996
). Our study was the first to genotype a significant number of samples from plaque, and unexpectedly showed that polymorphisms do exist between cardiovascular C. pneumoniae sources. Even though a limited amount of sequence was analysed, three of the genotypes observed were identical to previously identified human strains, while one was of animal origin, being the same genotype as that previously identified in both a frog and koalas (Berger et al., 1999
; Bodetti & Timms, 2000
; Wardrop et al., 1999
). Interestingly, ompA genotypes B, C and D appear to be geographically restricted to Australia, unlike genotype A, which has a worldwide distribution.
Human and koala PBMC specimens: ompA genotyping
Additional genotyping was performed on human PBMCs to determine whether genotypes AD of C. pneumoniae are restricted to vascular sites: C. pneumoniae was detected in two of the 43 human PBMC fractions using the ompA nested PCR procedure. One of these samples (huPBMC1) was able to be genotyped and was found to be ompA genotype D.
Given that human samples harboured a genotype of C. pneumoniae that is similar/identical to those previously found in koalas, this study examined whether only non-human strains of C. pneumoniae are present in koalas. Of the four koala-PBMC specimens analysed, one was infected with ompA genotype D and the other three were infected with ompA genotype A (Table 1). Therefore, genotypes D and A of C. pneumoniae are not restricted solely to humans or koalas.
The chlamydial strains of koala origin have previously shown minor sequence differences to the strains from human origin at several loci, including the groESL intergenic region, the16S rRNA gene, ompB and the VD4 region of the ompA gene (Glassick et al., 1996; Wardrop et al., 1999
). This is the first report of koala PBMCs being infected with a genotype of C. pneumoniae that is also found in humans. Other animals have previously been reported to harbour chlamydial infections with a genotype similar to A, including frog (Australia), turtle (USA), python (USA and Europe), puff adder (USA) and iguana (Central America) (Bodetti et al., 2002
).
Multiple genotypes present in a single patient: ompA genotyping
Multiple sections of atherosclerotic carotid material (n=26) from six CAD patients were tested separately, and each section was genotyped (Table 2). In the case of five patients (huCAD5, huCAD6, huCAD7, huCAD8 and huCAD9), the same genotype [huCAD5, huCAD7 (=genotype A), huCAD7, huCAD8, huCAD9 (=genotype D)] was detected in all of the subsamples analysed (two to seven sections per patient). A dual infection with two different genotypes of C. pneumoniae (genotypes A and D) was present within atherosclerotic plaque from one human CAD patient (huCAD1). Interestingly, the two different genotypes were not found in the same 30 µm section of the artery. To study the distribution of the C. pneumoniae genotypes in huCAD1, we produced 10 clones for each of two 30 µm sections of the carotid plaque. All 10 clones produced the same genotype (A or D).
|
ygeDurk genotyping
The 23 bp invertible region in the C. pneumoniae plasticity zone is in the forward orientation in eight reference strains (J138, CM1, CWL029, IOL207, TW10, TW183, VR1356 and WA97001; designated genotype I) and in the reverse orientation in one of the strains, AR39 (designated genotype II). Apart from this inversion, no other polymorphisms were identified within the 371 bp PCR product of the 10 human reference strains. The four human carotid (huCAD1, huCAD6, huCAD8, huCAD9) and one koala PBMC (KoPMBC1) specimens that were found to harbour C. pneumoniae of genotype D all had the 23 bp inverted region in the same orientation as J138 and had 3 bp differences within the ygeDurk region at positions 224938 (C to T), 225044 (C to T) and 225072 (T to C; designated genotype III; accession number AY427827; Fig. 2).
|
In summary, specific gene typing of the C. pneumoniae ompA and ygeDurk genes showed that there are minor polymorphisms present in C. pneumoniae strains infecting human atherosclerotic carotid plaque. Five different genotypes of C. pneumoniae were reported (genotypes A/I, A/II, B, C and D). Interestingly, two of these genotypes were of non-human origin, having now been reported in both humans and koalas. Our findings suggest that C. pneumoniae may be capable of being transmitted between humans and animals, although the origin and direction of transmission is presently unknown.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Blessing, E., Campbell, L. A., Rosenfeld, M. E., Chough, N. & Kuo, C. C. (2001). Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158, 1317.[CrossRef][Medline]
Bodetti, T. J. & Timms, P. (2000). Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas. Infect Immun 68, 27442747.
Bodetti, T. J., Jacobson, E., Wan, C., Hafner, L., Pospischil, A., Rose, K. & Timms, P. (2002). Molecular evidence to support the expansion of the host range of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Syst Appl Microbiol 25, 146152.[Medline]
Cochrane, M., Kalle, W. H., Roffey, P. & Moriarty, H. T. (2002). The detection of Chlamydia pneumoniae in atherosclerotic plaques of Australian subjects. Pathology 34, 270274.[CrossRef][Medline]
Everett, K. D. & Andersen, A. A. (1997). The ribosomal intergenic spacer and domain I of the 23S rRNA gene are phylogenetic markers for Chlamydia spp. Int J Syst Bacteriol 47, 461473.
Ezzahiri, R., Nelissen-Vrancken, H. J., Kurvers, H. A., Stassen, F. R., Vliegen, I., Grauls, G. E., van Pul, M. M., Kitslaar, P. J. & Bruggeman, C. A. (2002). Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc Res 56, 269.[CrossRef][Medline]
Fong, I. W., Chiu, B., Viira, E., Jang, D. & Mahony, J. B. (1999). De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immun 67, 60486055.
Gaydos, C. A., Quinn, T. C. & Eiden, J. J. (1992a). Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol 30, 796800.[Abstract]
Gaydos, C. A., Quinn, T. C., Bobo, L. D. & Eiden, J. J. (1992b). Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene. Infect Immun 60, 53195323.[Abstract]
Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A. & Quinn, T. C. (1996). Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64, 16141620.[Abstract]
Girjes, A. A., Carrick, F. N. & Lavin, M. F. (1994). Remarkable sequence relatedness in the DNA encoding the major outer membrane protein of Chlamydia psittaci (koala type I) and Chlamydia pneumoniae. Gene 138, 139142.[CrossRef][Medline]
Glassick, T., Giffard, P. & Timms, P. (1996). Outer membrane protein 2 gene sequences indicate that Chlamydia pecorum and Chlamydia pneumoniae cause infections in koalas. Syst Appl Microbiol 19, 457464.
Grayston, J. T., Campbell, L. A., Kuo, C. C., Mordhorst, C. H., Saikku, P., Thom, D. H. & Wang, S. P. (1990). A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161, 618625.[Medline]
Haranaga, S., Yamaguchi, H., Friedman, H., Izumi, S. & Yamamoto, Y. (2001). Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun 69, 77537759.
Herrmann, B., Winqvist, O., Mattsson, J. G. & Kirsebom, L. A. (1996). Differentiation of Chlamydia spp. by sequence determination and restriction endonuclease cleavage of RNase P RNA genes. J Clin Microbiol 34, 18971902.[Abstract]
Jackson, L. A., Campbell, L. A., Kuo, C. C., Rodriguez, D. I., Lee, A. & Grayston, J. T. (1997). Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176, 292295.[Medline]
Jantos, C. A., Heck, S., Roggendorf, R., Sen-Gupta, M. & Hegemann, J. H. (1997). Antigenic and molecular analyses of different Chlamydia pneumoniae strains. J Clin Microbiol 35, 620623.[Abstract]
Kuo, C. C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L. & Grayston, J. T. (1993). Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167, 841849.[Medline]
Leowattana, W., Pokum, S., Mahanonda, N. & Poungvarin, N. (2001). Rapid detection of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells of coronary artery disease patients by real-time fluorescence PCR. J Med Assoc Thai 84 Suppl 3, S658S668.[Medline]
Maass, M., Bartels, C., Engel, P. M., Mamat, U. & Sievers, H. H. (1998a). Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31, 827832.
Maass, M., Bartels, C., Kruger, S., Krause, E., Engel, P. M. & Dalhoff, K. (1998b). Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 140, S25S30.[CrossRef][Medline]
Molestina, R. E., Dean, D., Miller, R. D., Ramirez, J. A. & Summersgill, J. T. (1998). Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun 66, 13701376.
Pettersson, B., Andersson, A., Leitner, T., Olsvik, O., Uhlen, M., Storey, C. & Black, C. M. (1997). Evolutionary relationships among members of the genus Chlamydia based on 16S ribosomal DNA analysis. J Bacteriol 179, 41954205.
Pislaru, S. V., Van Ranst, M., Pislaru, C. & 7 other authors (2003). Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs. Cardiovasc Res 57, 834842.[CrossRef][Medline]
Ramirez, J. A. (1996). Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 125, 979982.
Rassu, M., Cazzavillan, S., Scagnelli, M. & 7 other authors (2001). Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 158, 7379.[CrossRef][Medline]
Read, T. D., Brunham, R. C., Shen, C. & 22 other authors (2000). Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28, 13971406.
Reed, K. D., Ruth, G. R., Meyer, J. A. & Shukla, S. K. (2000). Chlamydia pneumoniae infection in a breeding colony of African clawed frogs (Xenopus tropicalis). Emerg Infect Dis 6, 196199.[Medline]
Saikku, P., Leinonen, M., Mattila, K., Ekman, M. R., Nieminen, M. S., Makela, P. H., Huttunen, J. K. & Valtonen, V. (1988). Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983986.[Medline]
Sessa, R., Di Pietro, M., Schiavoni, G., Santino, I., Cipriani, P., Romano, S., Penco, M. & del Piano, M. (2001). Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis 159, 521525.[CrossRef][Medline]
Shirai, M., Hirakawa, H., Kimoto, M. & 8 other authors (2000a). Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res 28, 23112314.
Shirai, M., Hirakawa, H., Ouchi, K. & 18 other authors (2000b). Comparison of outer membrane protein genes omp and pmp in the whole genome sequences of Chlamydia pneumoniae isolates from Japan and the United States. J Infect Dis 181 Suppl 3, S524S527.[CrossRef][Medline]
Shor, A. & Phillips, J. I. (2000). Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis. Cardiovasc J S Afr 11, 1623.[Medline]
Shor, A., Phillips, J. I., Ong, G., Thomas, B. J. & Taylor-Robinson, D. (1998). Chlamydia pneumoniae in atheroma: consideration of criteria for causality. J Clin Pathol 51, 812817.[Abstract]
Storey, C., Lusher, M., Yates, P. & Richmond, S. (1993). Evidence for Chlamydia pneumoniae of non-human origin. J Gen Microbiol 139, 26212626.[Medline]
Taylor-Robinson, D. & Thomas, B. J. (1998). Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol 51, 793797.
Ward, M. (1995). The immunobiology and immunopathology of Chlamydia infections. APMIS 103, 769796.[Medline]
Wardrop, S., Fowler, A., O'Callaghan, P., Giffard, P. & Timms, P. (1999). Characterization of the koala biovar of Chlamydia pneumoniae at four gene loci ompAVD4, ompB, 16S rRNA, groESL spacer region. Syst Appl Microbiol 22, 2227.[Medline]
Received 24 November 2004;
revised 29 March 2005;
accepted 11 April 2005.
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
J MED MICROBIOL | ALL SGM JOURNALS |